6 Results

People

  1. Anand
    Anand
  2. Scher
    Scher
  3. Danila
    Danila
  4. Fleisher
    Fleisher
  5. Lilja
    Lilja
  6. Heller
    Heller
  7. Koscuiszka
    Koscuiszka
  8. Larson
    Larson
  9. Morris
    Morris
  10. Sawyers
    Sawyers

Groups

  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (3)
  5. Hematologic Malignancies, Division of (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)
  7. Population Sciences Research Program (3)
  8. Sloan Kettering Institute Faculty (3)
  9. Surgery (3)
  10. Urology (3)
  1. "prostate specific antigen"
  2. "Aseem Anand"
Formats
  1. Journal Article (6)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (3)
  5. Hematologic Malignancies, Division of (3)
  6. Molecular Pharmacology and Chemistry Program Faculty (3)

More Groups

People
  1. Aseem Anand (6)
  2. Howard Scher (6)
  3. Daniel Danila (4)
  4. Martin Fleisher (4)
  5. Hans Lilja (3)
  6. Charles Sawyers (2)

More People

Years
  1. 2011 (2)
  2. 2010 (2)
  3. 2009 (1)
  4. 2007 (1)
Publications
  1. Clinical Cancer Research (2)
  2. BJU International (1)
  3. Clinical Chemistry (1)
  4. European Urology (1)
  5. Lancet (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Science, Inc. (2)
  3. American Association for Clinical Chemistry (1)
  4. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
    Journal Article

    Danila, D. C.; Anand, A.; Sung, C. C.; Heller, G.; Leversha, M. A.; Cao, L.; Lilja, H.; Molina, A.; Sawyers, C. L.; Fleisher, M.; more...
    European Urology (2011)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Liu, G.; Carducci, M. A.; Eisenberger, M. A.; Anand, A.; Morris, M. J.; Slovin, S. F.; Sasaki, Y.; Takahashi, S.; Ozono, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study
    Journal Article

    Scher, H. I.; Anand, A.; Rathkopf, D.; Shelkey, J.; Morris, M. J.; Danila, D. C.; Larson, S.; Humm, J.; Fleisher, M.; Sawyers, C. L.; more...
    Lancet (2010)

    Fulltext@MSK | Save
  • Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
    Journal Article

    Donovan, M. J.; Osman, I.; Khan, F. M.; Vengrenyuk, Y.; Capodieci, P.; Koscuiszka, M.; Anand, A.; Cordon-Cardo, C.; Costa, J.; Scher, H. I.
    BJU International (2010)

    Fulltext@MSK | Save
  • Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: Concordance with CellSearch assay and association with bone metastases and with survival
    Journal Article

    Helo, P.; Cronin, A. M.; Danila, D. C.; Wenske, S.; Gonzalez-Espinoza, R.; Anand, A.; Koscuiszka, M.; Väänänen, R. M.; Pettersson, K.; Chun, F. K. H.; more...
    Clinical Chemistry (2009)

    Fulltext@MSK | Save
  • Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
    Journal Article

    Danila, D. C.; Heller, G.; Gignac, G. A.; Gonzalez-Espinoza, R.; Anand, A.; Tanaka, E.; Lilja, H.; Schwartz, L.; Larson, S.; Fleisher, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save